Recalcitrant dermatitis herpetiformis treated successfully with sulfasalazine
Authors:
- 1 April 2021
- journal article
- letter
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (4) , E149-E150
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridineRedox Report, 2010
- Abnormal liver function tests induced by dapsone in a patient with dermatitis herpetiformis and primary sclerosing cholangitisBritish Journal of Dermatology, 1999
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.Journal of Clinical Investigation, 1982